What they were paid
Zentalis Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $65,000 | $86,405 | $0 | $0 | $151,405 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zentalis Pharmaceuticals, Inc. DEF 14A filed April 30, 2026, accession 0001725160-26-000027, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Zentalis Pharmaceuticals pays directors a $45,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit · Compensation · Nominating/Governance (Chair)
The rest of the Zentalis Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| David Johnson | Independent Director | $139,251 |
| Enoch Kariuki, Pharm.D | Independent Director | $151,405 |
| Julie Eastland | Director | $0 |
| Luke Walker, M.D | Independent Director | $145,266 |
| Scott Myers | Independent Director | $184,136 |
The full Zentalis Pharmaceuticals compensation record
free company briefThis page is one director within Zentalis Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat